Immunotropic Properties of Anaferon and Anaferon Pediatric

Abstract

Anaferon and pediatric anaferon based on release-active antibodies to interferon-γ (R-A antibodies to INF-γ) proved to be efficient in the treatment of many viral infections. Immunomodulating (immunotropic) properties of the drugs were revealed in the preclinical studies at many Russian and foreign research medical institutions and are reviewed herein. Anaferon and pediatric anaferon stimulated the humoral and cellular immune responses and increased the neutrophil and macrophage activity. The crucial mechanism of the immunotropic action of R-A antibodies to INF-γ was the effect on the system of interferons and in particular on INF-γ and functionally conjugated cytokines, resulting in normalization of the functional activity of the innate factors of the immune defense and increasing of the antiviral action. The broad spectrum of the immunotropic activity provided the success of anaferon and anaferon pediatric for more than 10 years in the treatment and prophylaxis of the diseases associated with disorders in the immune system functional state.

Keywords

• anaferon
• pediatric anaferon
• release-active antibodies to inf-γ
• immunotropic activity
• immunomodulators
• antivirals